News

Moderna had designs on releasing a combined influenza and covid-19 vaccine after some promising trials, but this week the ...
Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...
U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...
The US Food and Drug Administration has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.
The FDA picked the LP.8.1 Covid strain for the fall vaccines, fueling concerns that the shots may be limited to only the most ...
The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.
An FDA advisory committee unanimously recommended Thursday that the next COVID vaccine should be a monovalent one in the JN.1 ...
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.
Dr. Peter McCullough testified Thursday at a Senate hearing on "The Corruption of Science and Federal Health Agencies: How Health Officials Downplayed and Hid Myocarditis and Other Adverse Events ...
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...